Naaju Breaking News, Live Updates, Latest Headlines, Viral News, Top Stories, Trending Topics, Videos
:quality(85)//cloudfront-us-east-1.images.arcpublishing.com/infobae/M5FGKUECB5CW3LA3O52DXRBWNI.jpg)
[ad_1]
:quality(85)/cloudfront-us-east-1.images.arcpublishing.com/infobae/SFDB627OOVD4DDRNFEVQ2OIXKQ.jpg)
The third phase of clinical trials of the Russian single-dose Sputnik Light vaccine against the coronavirus began this Saturday in Moscow. with the inoculation of almost half a thousand volunteers.
“Today, the first participants in the Sputnik Light vaccine research have been vaccinated. As the volunteers pass the exams, the number of vaccinated will increaseSaid the deputy mayor of Moscow, Anastasía Rákova, quoted by the Russian press agency Interfax.
According to the official, there is currently a registration process for active volunteering, 490 of whom have had medical examinations in the past two days and were vaccinated this Saturday.
Rákova noted that Sputnik Light will be used in the future in addition to the two-dose vaccine Sputnik V.
:quality(85)/cloudfront-us-east-1.images.arcpublishing.com/infobae/R6YTAZXBKFEAHGVLLVHIN2BV6I.jpg)
On February 18, the mayor of Moscow, Sergei Sobianin, announced that ten polyclinics in the capital would participate in this international phase, with a total of 6000 volunteers, 3000 from Moscow and the rest of the United Arab Emirates.
A day earlier, the Russian Ministry of Health had given the green light for the third phase of clinical trials of Sputnik Light.
Unlike Centro Gamaleya’s Sputnik V, which requires two injections with a 21-day break, Sputnik Light consists of a single dose.
Its effectiveness should be studied in the elderly
The director of the Gamaleya Center, Alexandr gintsburg, explained that the safety of the single-dose vaccine is “proven”, but its effectiveness for use in the elderly remains to be investigated.
In your opinion, Sputnik Light will be used to reduce mortality in situations where it is not possible to vaccinate with the two doses needed to strengthen immunity.
:quality(85)/cloudfront-us-east-1.images.arcpublishing.com/infobae/NQ2QNQ2XCND7FCZGHYUTB76AHE.jpg)
The President of Russia, Vladimir Poutine, presented in mid-December during the annual press conference the “Sputnik Light”, whose effectiveness he estimated at a 85%.
The chairman of the Russian Direct Investment Fund (FIDR), Kiril Dmitriev, assured that the Sputnik Light is intended for the outside market, and “may become a temporary and effective solution for many countries that are at the height of the disease and want to save as many lives as possible”.
The objective is maximize the number of people who have at least partial immunity, potentially reducing the number of severe cases and easing the burden on health systems.
Sputnik V will be produced in Argentina
Recently, Argentinian laboratory Richmond announced that it would produce Sputnik V, for which it will be necessary to build a factory in Pilar (Buenos Aires) with a minimum duration of one year to have the development in hand.
:quality(85)/cloudfront-us-east-1.images.arcpublishing.com/infobae/PZJTCZ2GE5GABAAVNZGKB5A3UA.jpg)
As he could confirm Infobae, Richmond has signed a preliminary and scientific cooperation agreement with the Russian Sovereign Investment Fund and with the participation of Hetero Labs Limited, a company established in the Republic of India and with which Richmond has a strategic alliance for more than 25 years.
Construction of the new high-tech vaccine production plant in Argentina will include Sputnik V vaccine against COVID-19 disease and other formulations too. Richmond also has advanced scientific studies, developments and applied research in the pursuit of treatment for HIV and hepatitis.
(With information from EFE)
[ad_2]
Source link
